The physiology of hypoxic response

When oxygen levels drop—whether at high altitude, during a heart attack, or inside a growing tumour—the body’s cells must scramble to adapt or die. This seven-year programme investigates the fundamental biological machinery that senses low oxygen and triggers survival responses, from ramping up red blood cell production to rewiring metabolism. The work splits into three strands: how healthy tissues cope with oxygen shortage, how the same pathways influence inflammation and infection, and how cancers hijack these systems to fuel tumour growth and spread, particularly in breast cancer. This is fundamental science—there is no immediate clinical tool or drug on the table. But the oxygen-sensing pathway has already produced one blockbuster: drugs that stabilise the key protein HIF are now used to treat anaemia in kidney disease. A deeper understanding of how hypoxia drives inflammation and metastasis could eventually point toward therapies that block cancer’s ability to thrive in low-oxygen environments, or that tweak immune responses during infection. For now, the payoff is a clearer map of a stress response that touches nearly every disease involving poor blood flow or rapid cell growth.